Status:
COMPLETED
Acute Health Effects of Passive Vape Among COPD Patients
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Electronic Cigarette Use
Second Hand Smoke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The use of e-cigarettes is often permitted in otherwise smoke-free areas causing passive vape exposure for present individuals. Little is known about the potential adverse health effects of passive va...
Detailed Description
Introduction: The use of e-cigarettes is often permitted in otherwise smoke-free areas causing passive vape exposure for present individuals. Little is known about the potential adverse health effects...
Eligibility Criteria
Inclusion
- Never smoker or ex-smokers ≥ 6 months
- Aged 18+
- A known diagnosis of COPD (FEV1/FVC \< lower limit of normal, app. 70%)
- MRC ≥ 2 or CAT score ≥ 10
Exclusion
- Exposure to smoking more than 30 min./day
- Treatment with inhaled or oral corticosteroids
- Known hypersensitivity to constituents in e-cigarettes
- Any other disease that could influence the study parameters
- Conditions that prevent safe access to the climate chambers (such as claustrophobia)
- Perennial rhinitis
- Deformed nasal airways
- Not being able to change from long-acting medication to short-acting medication
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04316234
Start Date
March 1 2017
End Date
November 30 2017
Last Update
March 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University
Aarhus, Central Region Denmark, Denmark, 8000